These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12828337)

  • 1. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J; Kutinová L; Smahel M; Nĕmecková S
    Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a needle-free delivery platform for prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus 2 glycoprotein D.
    Meseda CA; Stout RR; Weir JP
    Viral Immunol; 2006; 19(2):250-9. PubMed ID: 16817767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V; Kunke D; Hamsíková E; Kutinová L; Vonka V
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
    Hasan UA; Harper DR; Wren BW; Morrow WJ
    Vaccine; 2002 Jan; 20(9-10):1308-15. PubMed ID: 11818149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization.
    Massaer M; Haumont M; Garcia L; Mazzu L; Bollen A; Jacobs P; Jacquet A
    Viral Immunol; 1999; 12(3):227-36. PubMed ID: 10532651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
    Hasan UA; Harper DR; Argent S; Layton G; Wren BW; Morrow WJ
    Vaccine; 2000 Feb; 18(15):1506-14. PubMed ID: 10618548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
    Abendroth A; Slobedman B; Springer ML; Blau HM; Arvin AM
    Antiviral Res; 1999 Dec; 44(3):179-92. PubMed ID: 10651069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.
    Shinoda K; Wyatt LS; Irvine KR; Moss B
    Virol J; 2009 Mar; 6():28. PubMed ID: 19257896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection.
    Huang Y; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2006 Jun; 24(25):5349-59. PubMed ID: 16714071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
    Massaer M; Haumont M; Place M; Bollen A; Jacobs P
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():491-4. PubMed ID: 8383181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene.
    Nĕmecková S; Ludvíková V; Maresová L; Krystofová J; Hainz P; Kutinová L
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():211-5. PubMed ID: 8627224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
    Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
    Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
    Vafai A; Yang WN
    J Virol; 1991 Oct; 65(10):5593-6. PubMed ID: 1654454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary vaccination with vaccinia virus recombinants: role of residual virulence of recombinants and immunogenicity of extrinsic antigens.
    Kutinová L; Ludvíková V; Nemecková S; Hainz P; Simonová V; Vonka V
    Vaccine; 1999 Mar; 17(9-10):1186-92. PubMed ID: 10195631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus.
    Wang H; Zhang S; Xue W; Zeng Y; Liu L; Cui L; Liu H; Zhang Y; Chen L; Nie M; Zhang R; Chen Z; Hong C; Zheng Q; Cheng T; Gu Y; Li T; Xia N; Li S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice.
    Li D; Bian L; Cui L; Zhou J; Li G; Zhao X; Xing L; Cui J; Sun B; Jiang C; Kong W; Zhang Y; Chen Y
    Int J Nanomedicine; 2024; 19():8029-8042. PubMed ID: 39130684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.